{
  "url": "https://openlegislation.uk/medicines-control-of-substances-for-manufacture-order-1985/schedule-2",
  "json_url": "https://openlegislation.uk/medicines-control-of-substances-for-manufacture-order-1985/schedule-2.json",
  "legislation": "uksi/1985/1403",
  "legislation_title": "The Medicines (Control of Substances for Manufacture) Order 1985",
  "legislation_url": "https://openlegislation.uk/medicines-control-of-substances-for-manufacture-order-1985",
  "path": "schedule/2",
  "kind": "schedule",
  "number": "2",
  "heading": null,
  "text": "“Gentamicin” is any antimicrobial basic substance or mixture of such substances produced by the strain of Micromonospora purpurea which on 1st September 1967 was numbered NRRL 2953 in the culture collection of the Northern Utilisation Research and Development Branch of the United States Department of Agriculture. The expression includes any salt or derivative, or salt of a derivative, of gentamicin and any substance the chemical and biological properties of which are identical with or similar to those of gentamicin but which is' produced by other means.\n“Neomycin” is any antimicrobial substance or mixture of such substances produced by Streptomyces fradiae which are complex organic bases and which yield on hydrolysis with mineral acids the base neamine. The expression includes any salt or derivative, or salt of a derivative, of neomycin and any substance the chemical and biological properties of which are identical with or similar to those of neomycin but which is produced by other means.\n“Nystatin” is any mixture of antifungal polyenes produced by the growth of Streptomyces noursei and containing the chemical structure 19-(3-amino-3, 6-dideoxy-β-D-mannopyranosyloxy)-16-carboxy-3, 5, 7, 10, 11, 15, 17, 35-octahydroxy-34-methyl-13-oxo-octatriaconta-20, 24, 26, 30, 32-hexaen-37-olide. The expression includes any salt or derivative, or salt of a derivative, of nystatin and any substance the chemical and biological properties of which are identical with or similar to those of nystatin but which is produced by other means.\n“Parenteral injection” in relation to any substance includes any administration of the substance by insertion into the body by any route other than that of the gastro-intestinal tract but does not include any application of the substance to the skin.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/1985/1403/schedule/2",
    "retrieved_at": "2026-10-29T17:03:47.762857+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}